Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|April 30, 2003
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasoneM A Dimopoulos, C Tsatalas, A Zomas, et al.Haematologica|August 24, 1999
Outcome of biphenotypic acute leukemiaS Killick, E Matutes, R L Powles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Treatment of Waldenstrom's macroglobulinemia with thalidomideM A Dimopoulos, A Zomas, N A Viniou, et al.Bone Marrow Transplantation|November 1, 1994
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemiaA Zomas, J Mehta, R Powles, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 27, 2015
Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infectionS M Trifilio, R Heraty, A Zomas, et al.Leukemia & Lymphoma|August 1, 1997
Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemiaR Saso, A Zomas, M Hamblin, et al.Bone Marrow Transplantation|May 1, 1996
T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failureJ Mehta, R Powles, S Singhal, et al.Seminars in Hematology|October 1, 1996
Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemiaJ Mehta, R Powles, S Singhal, et al.Annals of Hematology|July 1, 1995
Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemiaA Zomas, J C Marsh, N K Harrison, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal functionM A Dimopoulos, E Kastritis, E Michalis, et al.Pageof 3